Forgot your password? 
New user? Location: Home » News
| Show: 1 - 10 of 103 results |
CROChina is Now Part of CROAsia - an Asia Pharma-Outsourcing Portal
|
[posted: May 28, 2009] We are now pleased to announce that we have launched a brand-new, multifunctional media platform - www.CROAsia.net, and we are in the progress of integrating CROChina.com into CROAsia.net ... ... details |
Sundia MediTech and Xcovery Announce Big Success in Drug Discovery
|
[posted: February 10, 2009] Sundia MediTech, a CRO company based in Shanghai, China and Xcovery, a company based in Florida, U.S.A. jointly announced their 2 year collaborative success in new drug discovery at IBC's BioProcess International Conference yesterday in San Diego, USA ... details |
WuXi Adopts H-Cube for Drug Discovery
|
[posted: January 06, 2009] WuXi AppTec is to use ThalesNano's H-Cube for laboratory-based hydrogenation, which the CRO believes offers advantages in drug discovery over traditional batch processes. By using the H-Cube WuXi joins illustrious company, with ThalesNano claiming that the world's top 20 pharmaceutical companies ... details |
PPD Acquires Merck's Vaccine Testing Lab
|
[posted: January 05, 2009] PPD, Inc. (Nasdaq: PPDI) today announced it has entered into a strategic collaboration with Merck & Co., Inc., involving vaccine testing and assay development. Under the agreements, PPD purchased Merck's 130,000 square-foot vaccine testing laboratory and related equipment in Wayne, Penn. ... details |
WuXi PharmaTech Shanghai Rodent Facility Awarded AAALAC Accreditation
|
[posted: December 18, 2008] WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that its rodent facility in Shanghai has received accreditation ... details |
PPD To Expand Central Lab into Singapore
|
[posted: December 17, 2008] PPD, Inc. plans to expand its global central lab services into Singapore in response to growing demand in Southeast Asia. The lab is expected to begin operations in mid-2009 and will provide biopharmaceutical clients with a "comprehensive range of highly customized lab services," ... details |
PRA Partners with Frontage Labs for Testing Services
|
[posted: December 03, 2008] PRA International has entered an agreement with Frontage Laboratories, Inc., enabling PRA Early Development Services' U.S. Clinical Pharmacology Center to offer full analytical lab testing services to its Phase I - IV trial services in North America ... details |
WuXi PharmaTech Discontinues Bio-Manufacturing in US
|
[posted: December 02, 2008] WuXi PharmaTech (Cayman) Inc. today announced it will dedicate its Philadelphia facility to the Company's expanding biologics testing, cell banking and cell therapy services, and as of December 31, 2008, WuXi will discontinue its U.S. biologics manufacturing operations ... details |
China's Kaifeng Pharmaceutical Expands Footprint in International API Markets
|
[posted: December 02, 2008] China's Kaifeng Pharmaceutical (Group), a subsidiary of Henan province-based Furen Medicines Group, is moving forward with its plan to grab a larger share of the global pharmaceutical market by seeking international certification and expanding its API ... details |
Terror Strike in India: Drug Firms May Lose Outsourcing Deals
|
[posted: December 01, 2008] Indian drug makers may lose out on outsourcing contracts as overseas pharmaceutical companies defer their visits to the country in the wake of Mumbai terror attacks, according to industry experts ... details |
